Evidence map›Paper›PMID 42231063›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026

De Novo Design of Multivalent α/β-Peptides Mimicking Transcription Factors Targeting the CBP KIX Domain.

Márk V Tresztián, Vencel L Petrovicz, Edit Wéber, Tamás A Martinek, Zsófia Hegedüs

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Márk V TresztiánDepartment of Medical Chemistry, University of Szeged, Szeged, Hungary.
Vencel L PetroviczDepartment of Medical Chemistry, University of Szeged, Szeged, Hungary.
Edit WéberDepartment of Medical Chemistry, University of Szeged, Szeged, Hungary.
Tamás A MartinekDepartment of Medical Chemistry, University of Szeged, Szeged, Hungary.ORCID https://orcid.org/0000-0003-3168-8066
Zsófia HegedüsDepartment of Medical Chemistry, University of Szeged, Szeged, Hungary.

Funding

János Bolyai Research Scholarship of the Hungarian Academy of SciencesMinistry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund TKP2021-EGA32National Academy of Scientist Education Program of the National Biomedical FoundationNational Research, Development and Innovation Office of Hungary, NKFIH 152867National Research, Development and Innovation Office of Hungary, NKFIH ADVANCED_25National Research, Development and Innovation Office of Hungary, NKFIH K134754University of Szeged, Albert Szent-Györgyi Medical SchoolUniversity of Szeged Open Access 8338
6 · The paper itself

Abstract

Protein-protein interactions that regulate gene expression in the nucleus are increasingly recognized as potential therapeutic targets but present unique challenges. Effective targeting requires molecules capable of interacting with large protein surfaces while remaining small enough to pass through the nuclear pore, for which peptidomimetics are promising candidates. De novo design strategies often focus on projecting hot-spot residues using well-defined, rigid scaffolds; however, other critical properties-such as solubility, charge, or local flexibility-are often overlooked. Our approach employs α/β-peptidomimetics to enable fine-tuning of these properties by generating manageable-sized soluble libraries. Using the KIX domain of the coactivator proteins p300/CBP as a model system, we demonstrate that our strategy allows modular optimization of hot-spot, solvent-exposed, and structure-inducing residues, thereby tuning affinity and binding-site selectivity. Coactivator proteins often use multivalency to enhance affinity and selectivity, which we exploit by creating dimers from our initial hits. We show that both static libraries and template-directed dynamic covalent chemistry facilitate the screening of multivalent ligands that closely mimic the native interaction partners. Our design strategy, built on α/β-peptide building blocks, represents a promising approach to develop de novo ligands against proteins characterized by high plasticity and multivalent interactions.

Indexed as

p300-CBP Transcription FactorsPeptidesPeptidomimeticsTranscription FactorsBinding SitesHumansProtein BindingProtein Domainsp300-CBP Transcription FactorsPeptidesPeptidomimeticsTranscription Factorsdynamic covalent chemistrypeptidomimeticstranscription factorsα/β‐peptides

Identifiers

PMID42231063
PMCPMC13587646

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.